Nano Labs Ltd shares fall 1.20% after-hours as HydroGraph partners with Hawkeye Bio for lung cancer screening product.

jueves, 14 de agosto de 2025, 5:38 pm ET1 min de lectura
NA--
Nano Labs Ltd. declined 1.20% in after-hours trading. The company announced a partnership with Hawkeye Bio and Ease Healthcare to develop a novel lung cancer screening product, LEAP, which is a non-invasive, radiation-free, and highly sensitive blood test designed to detect early signs of lung cancer.

Nano Labs Ltd shares fall 1.20% after-hours as HydroGraph partners with Hawkeye Bio for lung cancer screening product.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios